Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 16, 2024
Vascular response following implantation of the third-generation drug-eluting resorbable coronary magnesium scaffold: an intravascular imaging analysis of the BIOMAG-I first-in-human studyMasaru Seguchi, Alp Aytekin, Erion Xhepa, et al.
JACC. Cardiovascular Interventions|September 22, 2022
Rotational Atherectomy or Balloon-Based Techniques to Prepare Severely Calcified Coronary LesionsTobias Rheude, Sean Fitzgerald, Abdelhakim Allali, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 7, 2026
Outcomes of Patients With High-Risk Plaques Treated With a Bioresorbable Magnesium Scaffold: Insights From the BIOMAG-I StudyPablo M Rubio, Hector M Garcia-Garcia, Gebremedhin D Melaku, et al.
Cardiology and Therapy|December 6, 2023
Impact of Access Site on Periprocedural Bleeding and Cerebral and Coronary Events in High-Bleeding-Risk Percutaneous Coronary Intervention: Findings from the RIVA-PCI TrialMartin Borlich, Uwe Zeymer, Harm Wienbergen, et al.
European Heart Journal. Cardiovascular Imaging|November 8, 2023
Temporal changes in coronary plaque as assessed by an artificial intelligence-based optical coherence tomography: from the first-in-human trial on DREAMS 3G scaffoldHector M Garcia-Garcia, Ron Waksman, Gebremedhin D Melaku, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 14, 2019
First Report of Edge Vascular Response at 12 Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial Sub-StudyAlexandre Hideo-Kajita, Hector M Garcia-Garcia, Michael Haude, et al.
JACC. Cardiovascular Interventions|February 19, 2025
1-Month or 3-Month DAPT in Women and Men at High Bleeding Risk Undergoing PCIVijay Kunadian, Mauro Gitto, Birgit Vogel, et al.
The American Journal of Cardiology|June 13, 2024
One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney DiseaseNader Mankerious, Ralph Toelg, Birgit Vogel, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 20, 2022
Access Route and Clinical Outcomes After Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome Undergoing Invasive Treatment StrategyRayyan Hemetsberger, Gert Richardt, Shqipdona Lahu, et al.
The Canadian Journal of Cardiology|December 26, 2023
In-hospital Outcomes of Rotational Atherectomy in ST-Elevation Myocardial Infarction: Results From the Multicentre ROTA-STEMI NetworkRayyan Hemetsberger, Nader Mankerious, Guillem Muntané-Carol, et al.
Pageof 11